Metraipolis › archive › dc_b0b2b159fb7d

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41306981
DOI
10.3389/fimmu.2025.1671251
License (as archived)
solo-consultazione
Archived
2026-11-08T16:02:20.378Z
SHA-256 of the archived text
a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20
Stable URL of this page
https://metraipolis.com/documento/dc_b0b2b159fb7d

How to cite

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981 — Europe PMC (en), https://europepmc.org/article/MED/41306981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0b2b159fb7d (Metraipolis archive dc_b0b2b159fb7d, sha256 a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20)
BibTeX
@misc{dcb0b2b159fb7d,
  title = {Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study — Europe PMC PMID:41306981},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41306981},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0b2b159fb7d; sha256 a2bb2563b6668c5e1566c76a3dee0e514697e68e8da357a2f3af5acaabba7f20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306981. Agents can read the archived copy with the MCP tool read_document.